Kodiak Sciences' (KOD) Sell Rating Reiterated at The Goldman Sachs Group

The Goldman Sachs Group reaffirmed their sell rating on shares of Kodiak Sciences (NASDAQ:KOD – Free Report) in a research note published on Monday, MarketBeat reports. The Goldman Sachs Group currently has a $2.00 price target on the stock. Separately, Capital One Financial raised Kodiak Sciences from an equal weight rating to an overweight rating […]

Related Keywords

United States ,American , ,Analyst Recommendations For Kodiak Sciences ,Goldman Sachs Group ,Kodiak Sciences Company Profile ,News Ratings For Kodiak Sciences Daily ,American Century Companies Inc ,Tower Research Capital ,Sg Americas Securities ,Kodiak Sciences ,Kodiak Sciences Inc ,Kodiak Sciences Stock Performance ,Free Report ,Capital One Financial ,Get Free Report ,Research Capital ,Century Companies ,Sciences Inc ,Kodiak Sciences Daily ,Nasdaq Kod ,Skod ,Medical ,Reiterated Rating ,The Goldman Sachs Group Inc ,